What Is Maqui Berry? Benefits, Science, and the Best Supplement Option

Maqui berry has the highest antioxidant capacity of any known fruit. But not all supplements deliver the same results — and the difference comes down to what's actually inside. Here's what the research shows, and what to look for.

Maqui berry (Aristotelia chilensis) is a deep-purple superfruit native to the temperate forests of Patagonia in southern Chile. For centuries, local Chilean communities harvested it wild from the forest floor, using it as a food source and for its remarkable restorative properties.

Today, maqui berry has drawn significant scientific interest — not just because of its rich antioxidant profile, but because standardized extracts derived from it have been studied in peer-reviewed human clinical trials for specific health outcomes. That distinction matters more than most people realize when choosing a supplement.

This article covers what maqui berry is, what the research actually shows, and what separates a clinically validated supplement from a generic powder.

What Makes Maqui Berry Unique?

Among all fruits and berries tested for antioxidant capacity, maqui berry consistently ranks at the top. Its ORAC 5.0 score — a measure of the ability to neutralize reactive oxygen species — reaches 30,852 µmol Trolox equivalents per gram, measured by Brunswick Laboratories (USA). For reference, that is more than four times higher than acai and approximately ten times higher than blueberries.

The reason lies in its unusually high concentration of delphinidins — a specific class of anthocyanins found in very few fruits. Delphinidins are not just another antioxidant. Research shows they:

• Neutralize all five major reactive oxygen species, including peroxyl, hydroxyl, peroxynitrite, singlet oxygen, and superoxide
• Downregulate NF-κB inflammatory pathways
• Activate PPARγ receptors involved in glucose metabolism and insulin sensitivity
• Penetrate specific tissue types — including lacrimal gland cells and dermal cells — where other antioxidants show limited bioavailability

Key Health Benefits: What the Clinical Research Shows

Eye Health and Dry Eye Relief

This is the area where maqui berry extract has the most direct and specific clinical evidence.

A double-blind, placebo-controlled study found that 60 mg per day of MaquiBright® — a standardized maqui berry extract — increased tear fluid production by 25% versus placebo after just 4 weeks. Over 60 days, participants reported approximately 75% reduction in dry eye symptom severity.

The mechanism is specific: delphinidins — particularly delphinidin-3,5-diglucoside (D3G5G) — reach the lacrimal glands and reduce oxidative stress at the cellular level, helping restore the gland's natural secretory function. This is a fundamentally different approach from artificial tears, which provide temporary relief without addressing the underlying oxidative damage.

Patent: WO 2014/098092 — Dry Eye Treatment Composition.

👉 Learn more about MaquiBright®

Blood Sugar and Metabolic Health

A clinical trial published in Pan Minerva Medica (2016) found that daily supplementation with Delphinol® — the metabolic-focused standardized maqui extract — produced the following results in prediabetic subjects over 90 days:

• HbA1c decreased from 5.65% to 5.35%
• LDL cholesterol reduced by approximately 14%
• HDL cholesterol improved

Patent: PCT/IB2010/002698 — Antioxidant and metabolic applications.

👉 Learn more about Delphinol®

Skin Health and Healthy Aging

A clinical study evaluated the effects of Delphinol® on skin health markers over 90 days, with the following results:

• +39% increase in skin elasticity
• +22% increase in dermal thickness (measured by ultrasound)
• 90% of participants reported visible improvement in skin firmness

Additional in vitro research confirms that delphinidins protect human skin fibroblasts from UVB-induced oxidative damage and inhibit the enzymes responsible for collagen degradation — a key mechanism in photoaging.

Antioxidant and Anti-inflammatory Effects

Beyond the condition-specific outcomes above, the broader antioxidant and anti-inflammatory profile of maqui berry has been studied in several contexts:

In vivo research also showed that Delphinol® reduced inflammatory edema by 35%, comparable to diclofenac, through NF-κB pathway downregulation — positioning maqui berry extract as an ingredient with measurable anti-inflammatory activity at clinically relevant doses.

👉 Full list of peer-reviewed clinical studies and publications

How to Choose the Best Maqui Berry Supplement

Generic maqui berry powder — freeze-dried berry powder in capsule or bag form — is widely available. It contains some anthocyanins and antioxidant activity, but at variable and unstandardized concentrations. The clinical studies described above were not conducted on generic powders. They were conducted on specific, standardized extracts with verified delphinidin content.

What to look for on the label:

• "Standardized to ≥25% delphinidins and ≥35% total anthocyanins" — this is the specification used in the clinical trials
• The branded ingredient name: Delphinol® (metabolic and skin health) or MaquiBright® (eye health)
• GRAS (Generally Recognized As Safe) status — MaquiBright® is GRAS affirmed in the United States
• Full traceability: wild-harvested from Patagonia, processed under GMP-certified conditions

Supplement brands that use the clinically validated ingredient include Life Extension (Tear Support with MaquiBright®), NOW Foods (Eye Moisturize with MaquiBright®), and Swanson Health. When purchasing, confirm the standardized extract name on the supplement facts panel.

The Science Behind MNL Group's Maqui Extracts

MNL Group is the company behind Delphinol® and MaquiBright® — two of the only maqui berry ingredients with a published portfolio of peer-reviewed human clinical studies.

Founded on over 15 years of research into Aristotelia chilensis, MNL Group works directly with wild harvesting communities in southern Chile, ensuring full traceability from forest to extract. Processing is carried out by Anklam Extrakt GmbH in Germany under certified GMP and HACCP standards.

• 3 active patents covering metabolic, eye health, skin, and anti-aging applications
• 15+ years of clinical and pre-clinical research into Aristotelia chilensis
• ORAC 5.0: 30,852 µmol TE/g — one of the highest antioxidant profiles measured worldwide
• Full supply chain traceability from Patagonian wild harvest to finished extract
• Research collaborations across Japan, Chile, Brazil, and Europe

For supplement brands, nutraceutical formulators, and functional food manufacturers seeking a clinically validated maqui berry ingredient, MNL Group provides full technical support, documentation, and supply chain traceability.

Frequently Asked Questions

Discover More